Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-12
DOI
10.1007/s10557-021-07168-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
- (2020) Shizuya Yamashita et al. Current Atherosclerosis Reports
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndrome
- (2020) Mayui Nakazawa et al. ATHEROSCLEROSIS
- Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
- (2020) Oluwayemisi Esan et al. Drug Design Development and Therapy
- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
- (2020) Matthew J Budoff et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
- (2020) Daniel Gaudet et al. EUROPEAN HEART JOURNAL
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evinacumab in Patients with Refractory Hypercholesterolemia
- (2020) Robert S. Rosenson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
- (2019) Koutaro Yokote et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography
- (2019) Andrew Lin et al. ATHEROSCLEROSIS
- Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study
- (2019) Robert S. Rosenson et al. DIABETOLOGIA
- ApoC-III ASO Promotes Tissue LPL Activity in Absence of ApoE-Mediated TRL Clearance
- (2019) Bastian Ramms et al. JOURNAL OF LIPID RESEARCH
- Structure of lipoprotein lipase in complex with GPIHBP1
- (2019) Rishi Arora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia
- (2019) Charles Desmarchelier et al. Nutrients
- Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
- (2019) Zahid Ahmad et al. CIRCULATION
- Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
- (2019) Nicholas A. Marston et al. CIRCULATION
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding why REDUCE-IT was positive – Mechanistic overview of eicosapentaenoic acid
- (2019) William S. Harris PROGRESS IN CARDIOVASCULAR DISEASES
- Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials
- (2018) Dean J. Kereiakes et al. ATHEROSCLEROSIS
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
- (2018) Bastian Ramms et al. CURRENT OPINION IN LIPIDOLOGY
- Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C
- (2018) Michael H Davidson EUROPEAN HEART JOURNAL
- Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue
- (2018) Wieneke Dijk et al. Journal of Clinical Lipidology
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis
- (2018) Gabriel Birrane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients
- (2018) Osman Ahmed et al. Journal of the American Heart Association
- HDL modification
- (2018) John T. Wilkins et al. CURRENT OPINION IN LIPIDOLOGY
- Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease
- (2017) Amit V. Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
- (2017) Sadao Takahashi Journal of Atherosclerosis and Thrombosis
- Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL
- (2017) Mikael Larsson et al. JOURNAL OF LIPID RESEARCH
- Exome-wide association study of plasma lipids in >300,000 individuals
- (2017) Dajiang J Liu et al. NATURE GENETICS
- A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
- (2017) Sumeet A Khetarpal et al. NATURE MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin
- (2017) Robert P. Giugliano et al. JAMA Cardiology
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
- (2016) Shun Ishibashi et al. ATHEROSCLEROSIS
- Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
- (2016) Robert S. Rosenson et al. CARDIOVASCULAR DRUGS AND THERAPY
- FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
- (2016) Christian Schlein et al. Cell Metabolism
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
- (2015) Moritz C. Wyler von Ballmoos et al. Journal of Clinical Lipidology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physiological regulation of lipoprotein lipase
- (2014) Sander Kersten BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study
- (2014) M. Thomsen et al. CLINICAL CHEMISTRY
- Apolipoprotein E isoforms and lipoprotein metabolism
- (2014) Michael C. Phillips IUBMB LIFE
- Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
- (2014) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
- (2014) Ron Do et al. NATURE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice
- (2013) Erin M. Foley et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: Key players in intestinal physiology and metabolic disorders
- (2013) Sylvie Demignot et al. BIOCHIMIE
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
- (2013) Paul Jellinger et al. Endocrine Practice
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis
- (2013) Ilenia Minicocci et al. JOURNAL OF LIPID RESEARCH
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes
- (2013) John J. Albers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Common variants associated with plasma triglycerides and risk for coronary artery disease
- (2013) Ron Do et al. NATURE GENETICS
- Demystifying the management of hypertriglyceridaemia
- (2013) Gerald F. Watts et al. Nature Reviews Cardiology
- Triglyceride-Rich Lipoprotein Modulates Endothelial Vascular Cell Adhesion Molecule (VCAM)-1 Expression via Differential Regulation of Endoplasmic Reticulum Stress
- (2013) Ying I. Wang et al. PLoS One
- Hypertriglyceridemia
- (2013) Amanda Brahm et al. Nutrients
- Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
- (2013) Carlos O. Mendivil et al. Journal of the American Heart Association
- Severe Hypertriglyceridemia With Pancreatitis
- (2013) Frank M. Sacks et al. JAMA Internal Medicine
- Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity
- (2012) Martin Adiels et al. ATHEROSCLEROSIS
- IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal
- (2012) Chongxiu Sun et al. CIRCULATION RESEARCH
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism
- (2012) Margaret R. Diffenderfer et al. JOURNAL OF LIPID RESEARCH
- Docosahexaenoic acid suppresses the expression of FoxO and its target genes
- (2012) Yu-Jen Chen et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Gut-liver interaction in triglyceride-rich lipoprotein metabolism
- (2011) Changting Xiao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The proteome of cytosolic lipid droplets isolated from differentiated Caco-2/TC7 enterocytes reveals cell-specific characteristics
- (2011) Julien Bouchoux et al. BIOLOGY OF THE CELL
- Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease
- (2011) Rachel R. Huxley et al. CIRCULATION
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- CD11c/CD18 Expression Is Upregulated on Blood Monocytes During Hypertriglyceridemia and Enhances Adhesion to Vascular Cell Adhesion Molecule-1
- (2010) R. Michael Gower et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The mechanism of the formation and secretion of chylomicrons
- (2010) Tammy Kindel et al. ATHEROSCLEROSIS SUPPLEMENTS
- Efficacy and Safety of Ezetimibe for Japanese Patients with Dyslipidaemia
- (2010) Yasunori Sawayama et al. CLINICAL DRUG INVESTIGATION
- Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases
- (2010) Jun Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Fatty acid flux in adipocytes: The in's and out's of fat cell lipid trafficking
- (2009) Brian R. Thompson et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PKC -mediated phosphorylation controls budding of the pre-chylomicron transport vesicle
- (2008) S. A. Siddiqi et al. JOURNAL OF CELL SCIENCE
- Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study
- (2008) Aaron R. Folsom et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started